Page images
PDF
EPUB

whole or in part, to advocate or promote gun control.

Sec. 253. Notwithstanding any other provision of this Act, no funds appropriated in this Act shall be used to carry out any program of distributing sterile needles or syringes for the hypodermic injection of illegal drugs.

Sec. 738. None of the funds made available by this Act may be used to enter into a contract, memorandum of understanding, or cooperative agreement with, make a grant to, or provide a loan or loan guarantee to any corporation that was convicted (or had an officer or agent of such corporation acting on behalf of the corporation convicted) of a felony criminal violation under any Federal or State law within the preceding 24 months, where the awarding agency is aware of the conviction, unless the agency has considered suspension or debarment of the corporation, or such officer or agent, and made a determination that this further action is not necessary to protect the interests of the Government.

Sec. 739. None of the funds made available by this Act may be used to enter into a contract, memorandum of understanding, or cooperative agreement with, make a grant to, or provide a loan or loan guarantee to, any corporation that any unpaid Federal tax liability that had been assessed, for which judicial and administrative remedies have been exhausted or have parsed, and that is not being paid in a timely manner pursuant to an agreement with the authority responsible for collecting the tax liability, where the awarding agency is aware of the unpaid tax liability, unless the agency has considered suspension of debarment of the corporation and made a determination that this further action is not necessary to protect the interests of the Government.

Section 433. None of the funds made available by this Act may be used to enter into a contract, memorandum of understanding, or cooperative agreement with, made a grant to, or provide a loan or loan guarantee to, any corporation that was convicted (or had an officer or agent of such corporation acting on behalf of the corporation convicted) of a felony criminal violation under any Federal law within the preceding 24 months, where the awarding agency is aware of the conviction, unless the agency has considered suspension or debarment of the corporation, or such officer or agent and made a determination that this further action is not necessary to protect the interests of the Government.

Section 434. None of the funds made available by this Act may be used to enter into a grant to, memorandum of understanding, or cooperative agreement with, make a grant to, or provide a loan or loan guarantee to, any corporation with respect to which any unpaid Federal tax liability that has been assessed for which all judicial and administrative remedies have been exhausted or have lapsed, and that is not being paid in a timely manner pursuant to an agreement with the authority responsible for collecting the tax liability, unless the agency has considered suspension or debarment of the corporation and made a determination that the suspension or debarment is not necessary to protect the interests of the Government.

Recipients may not use funds for research.

Recipients may not use funds for clinical care and pharmaceutical products. Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. Recipients may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.

Reimbursement of pre-award costs is not allowed.

Applicant Eligibility:

Eligibility includes all 50 states, Washington D.C., Puerto Rico, the U.S. Virgin
Islands, Guam, American Samoa, Palau, and the Federated States of
Micronesia, who are currently funded through the Behavioral Risk Factor
Surveillance System (BRFSS) Funding Opportunity Announcements
(CDC-RFA-SO11-1101 and CDC-RFA-SO11-1102).

Beneficiary Eligibility:

Any U.S. State, political subdivision, and U.S. Territories as described above. Credentials/Documentation:

Applicants should document a detailed work plan for meeting the objectives of the project, outline their method of operation, describe their evaluation procedures, and provide a budget with justification of funds requested. Applicants must comply with Administrative Requirements (ARs) outlined in 45 CFR Part 74 or Part 92 as appropriate. 2 CFR 200, Subpart E - Cost Principles applies to this program. Preapplication Coordination:

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application Procedures:

This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Applicants must download the SF424 (R&R) application package associated with this supplemental funding opportunity from www.Grants.gov. If access to the internet is not available or if the applicant encounters difficulty accessing the forms on-line, contact the HHS/CDC Procurement and grants Office Technical Information Management Section (PGOTIMS) staff at (770) 477-2700 for further instructions. HHS/CDC Telecommunications for the hearing impaired or disabled is available at TTY 1-888-232-6348.

If an applicant encounters technical difficulties with www.Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week, with the exception of all Federal Holidays. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it is needed. Applicants can reach the Grants.gov Support Center at 1-800-518-4726 or by e-mail at support@grants.gov. Submissions sent by e-mail, fax, CDs or thumb drives of applications will not be accepted. Award Procedure:

Eligible applications will be jointly reviewed for responsiveness by the National Center for Chronic Disease Prevention and Health Promotion and the CDC Procurement and Grants Office. Incomplete applications and applications that are non-responsive will not advance through the review process. Recipients will be notified in writing of the results.

A technical review panel within the Population Health Surveillance Branch (PHSB), Division of Population Health (DPH), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), CDC, will evaluate complete and responsive supplemental applications according to the published review criteria. Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be only binding, authorizing document between the recipient and the CDC. The NoA will be signed by an authorized Grants Management Officer and e-mailed to the program director. A hard copy of the NoA will be mailed to the recipient fiscal officer identified in the application. Unsuccessful recipients will receive notification of the results of the application review by mail. Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:

21-45 days after application submission deadline. Appeals:

Not Applicable.

Renewals:

Renewals will be based on the conditions in the supplemental funding announcement and are subject to the availability of funds under Section 301 of the Public Health Service Act (as amended) and Section 4002 of the Patient Protection and Affordable Care Act, Public Law 111-148.

Formula and Matching Requirements:

Statutory formulas are not applicable to this program.

This program has no matching requirements.

This program does not have MOE requirements. This program does not have MOE requirements.

Length and Time Phasing of Assistance:

Financial assistance is available for a 12-month budget period and a 22-month project period. See the following for information on how assistance is awarded/released: Funds will be awarded as a lump sum through a Notice of Award (NoA) from the agency Procurement and Grants Office. Reports:

Federal Funding Accountability and Transparency Act of 2006 (FFATA):

Public Law 109-282, the Federal Funding Accountability and Transparency Act of 2006 as amended (FFATA), requires full disclosure of all entities and organizations receiving Federal funds including grants, contracts, loans and other assistance and payments through a single publicly accessible web site, www.USASpending.gov. The Web site includes information on each Federal financial assistance award and contract over $25,000, including such information as:

1. The name of the entity receiving the award

2. The amount of the award

3. Information on the award including transaction type, funding agency, etc. 4. The location of the entity receiving the award

5. A unique identifier of the entity receiving the award; and

6. Names and compensation of highly-compensated officers (as applicable) Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by recipients: 1) information on executive compensation when not already reported through the Central Contractor Registry; and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000. For the full text of the requirements under the Federal Funding Accountability and Transparency Act of 2006, please view the following web site: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&d ocid=f.s2590enr.txt.pdf. Cash reports are not applicable. Federal Funding Accountability and Transparency Act of 2006 (FFATA): Public Law 109-282, the Federal Funding Accountability and Transparency Act of 2006 as amended (FFATA), requires full disclosure of all entities and organizations receiving Federal funds including grants, contracts, loans and other assistance and payments through a single publicly accessible web site,

www.USASpending.gov. The Web site includes information on each Federal financial assistance award and contract over $25,000, including such information as:

1. The name of the entity receiving the award

2. The amount of the award

3. Information on the award including transaction type, funding agency, etc.

4. The location of the entity receiving the award

5. A unique identifier of the entity receiving the award; and

6. Names and compensation of highly-compensated officers (as applicable) Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by recipients: 1) information on executive compensation when not already reported through the Central Contractor Registry; and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000. For the full text of the requirements under the Federal Funding Accountability and Transparency Act of 2006, please view the following web site: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&d ocid=f.s2590enr.txt.pdf. Federal Funding Accountability and Transparency Act of 2006 (FFATA): Public Law 109-282, the Federal Funding Accountability and Transparency Act of 2006 as amended (FFATA), requires full disclosure of all entities and organizations receiving Federal funds including grants, contracts, loans and other assistance and payments through a single publicly accessible web site, www.USASpending.gov. The Web site includes information on each Federal financial assistance award and contract over $25,000, including such information as:

1. The name of the entity receiving the award

2. The amount of the award

3. Information on the award including transaction type, funding agency, etc.

4. The location of the entity receiving the award

5. A unique identifier of the entity receiving the award; and

6. Names and compensation of highly-compensated officers (as applicable) Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by recipients: 1) information on executive compensation when not already reported through the Central Contractor Registry; and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000. For the full text of the requirements under the Federal Funding Accountability and Transparency Act of 2006, please view the following web site: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&d ocid=f.s2590enr.txt.pdf. Federal Funding Accountability and Transparency Act of 2006 (FFATA): Public Law 109-282, the Federal Funding Accountability and Transparency Act of 2006 as amended (FFATA), requires full disclosure of

all entities and organizations receiving Federal funds including grants, contracts, loans and other assistance and payments through a single publicly accessible web site, www.USASpending.gov. The Web site includes information on each Federal financial assistance award and contract over $25,000, including such information as:

1. The name of the entity receiving the award

2. The amount of the award

3. Information on the award including transaction type, funding agency, etc. 4. The location of the entity receiving the award

5. A unique identifier of the entity receiving the award; and

6. Names and compensation of highly-compensated officers (as applicable) Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by recipients: 1) information on executive compensation when not already reported through the Central Contractor Registry; and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000. For the full text of the requirements under the Federal Funding Accountability and Transparency Act of 2006, please view the following web site: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&d

ocid=f.s2590enr.txt.pdf.

Audits:

No audits are required for this program.

Records:

Records must follow the Records Management protocols.

Account Identification:

75-0943-0-1-551 - Authorization is: 75-12-0943 Fund No.: 09216020121DBM BACS No.: H008131101.

Obligations:

(Cooperative Agreements) FY 16 $4,000,000; FY 17 est $4,107,581; and FY 18 est $4,107,581 - Future year funding is subject to availability of funds. Range and Average of Financial Assistance:

Awards will range from approximately $50,000 through $125,000 with an average award of approximately $80,000 for FY12.

Awards will range from approximately $50,000 through $100,000 with an average award of approximately $68,000 for FY13.

TAFS Codes:

75-0943-0-1.

PROGRAM ACCOMPLISHMENTS:

Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:

Regulations governing this program are published under 45 Code of Federal Regulations (CFR) Part 74 or Part 92, as appropriate. For competing supplements, Administrative Regulations (ARS) remain in effect as published in the original funding announcement. For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address:

http://www.access.gpo.gov/nara/cfr-table-search.html.

Regional or Local Office:

None.

Headquarters Office:

Selma R. Moore 2500 Century Parkway, Atlanta, Georgia 30345 Email: gwn5@cdc.gov Phone: 4044986558

Website Address:

http://www.grants.gov

RELATED PROGRAMS:

93.283 Centers for Disease Control and Prevention_Investigations and Technical Assistance; 93.988 Cooperative Agreements for State-Based Diabetes Control Programs and Evaluation of Surveillance Systems EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

Applications will be reviewed for completeness by the Procurement and Grants

Office (PGO) staff and for responsiveness jointly by the National Center for Chronic Disease Prevention and Health Promotion and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements.

CDC will conduct a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information within the supplemental funding opportunity announcement. Applicants will be notified if their application did not meet program requirements.

93.747 ELDER ABUSE PREVENTION INTERVENTIONS PROGRAM Elder Abuse Prevention Intervention Projects

FEDERAL AGENCY:

Administration for Community Living, Department of Health and Human Services

AUTHORIZATION:

Section 2042 of the Patient Protection and Affordable Care Act, Section 411 of the Older Americans Act, and Section 4002 of the Affordable Care Act (PPHF). OBJECTIVES:

To develop, implement, and evaluate successful or promising interventions, practices, and programs to prevent elder abuse, neglect, and exploitation, including adult protective services programs. Through this program, ACL hopes to demonstrate how existing research can be used to craft new, useful programs to address elder abuse, neglect, and exploitation and improve and enhance adult protective services programming. TYPES OF ASSISTANCE:

Cooperative Agreements (Discretionary Grants)

USES AND USE RESTRICTIONS:

The use of these funds is to support primary, secondary, and/or tertiary elder abuse, neglect, and exploitation activities, interventions, and programs. (a) state and tribal efforts to develop successful prevention interventions using existing research in order to prevent and detect elder abuse, neglect, and exploitation; (b) building on the scientific and programmatic knowledge base by developing and evaluating new elder abuse, neglect, and exploitation interventions; (c) enhance the quality, consistency, and effectiveness of adult protective services secondary and tertiary prevention activities. The following activities are not fundable: Construction and/or major rehabilitation of buildings, Basic research (e.g. scientific or medical experiments), Continuation of existing projects without expansion, and Pre-award costs.

Applicant Eligibility:

Eligible entities for grants authorized under Section 411 of the Older Americans Act are: domestic public or private non-profit entities including state and local governments, Indian tribal governments and organizations (American Indian/Alaskan Native/Native American), faith-based organizations, community-based organizations, hospitals, and institutions of higher education, are eligible. For grants authorized under Section 2042 of the Patient Protection and Affordable Care Act, state government entities are eligible to apply. Beneficiary Eligibility:

The ultimate beneficiaries of this funding opportunity are older adults who are at risk of experiencing some form of elder maltreatment. Credentials/Documentation:

The application must include a letter of commitment from identified partners, with specific details on how the partner will substantively contribute to the achievement of the project's goals and objectives. Letters of intent apply are requested. 2 CFR 200, Subpart E-Cost Principles applies to this program. Preapplication Coordination:

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application Procedures:

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Application materials will be published on the Grants.gov website (http://www.grants.gov) or the AOA website (http://www.aoa.gov/AoARoot/Grants/Funding/index.aspx

).

ACL/AOA is requiring applications for all announcements to be submitted electronically through http://www.grants.gov.

Award Procedure:

Merit review of all applications and issuance of a Notice of Award to the grantee.

Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:
From 60 to 90 days.

Appeals:

Not Applicable. Renewals:

Not Applicable.

Formula and Matching Requirements:

Statutory formulas are not applicable to this program.
Matching Requirements: Percent: 25%.

This program has MOE requirements, see funding agency for further details.
Length and Time Phasing of Assistance:

Cooperative agreements will be made for up to a 3 year period, depending upon funding availability. Grant extensions are available and may be requested from the grantees Project Officer. Method of awarding/releasing assistance: by letter of credit.

Reports:

Grantees will also be expected to comply with new reporting requirements related to the Prevention and Public Health Fund. Grantees are required to complete the federal cash transactions portion of the SF-425 within the Payment Managements System as identified in their award documents through the life of the grant. Semi-annual progress reports are required. The fully completed SF-425 is required as denoted in the Notice of Award terms and conditions. Semi-annual progress reports is required. Grantees will be expected to work through AoA project officers to report on data for the purposes of a multi-component evaluation.

Audits:

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. In accordance with the provisions of Subpart F-Audit Requirements, under 45 CFR Part 75.500, nonfederal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year. Except as noted in 45 CFR Part 75.500.

Records:

Records must be maintained for 3 years after submission of the final financial report.

Account Identification:

75-0142-0-1-506.

Obligations:

(Cooperative Agreements (Discretionary Grants)) FY 16 $0; FY 17 est $0; and FY 18 Estimate Not Available - not available.

Range and Average of Financial Assistance:
No Data Available.

TAFS Codes:

75-12-0142.

PROGRAM ACCOMPLISHMENTS:

Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:

All grantees must comply with all requirements specified for grants funded through the Prevention and Public Health fund. Grantees also must comply with polices outlined in HHS Grants Policy Statement located at http://www.hhs.gov/asfr/ogapa/grantinformation/hhsgps107.pdf

Regional or Local Office:

None.

Headquarters Office:

Stephanie WhittierEliason Administration on Aging

Administration for Community Living

330 C Street, SW, Washington, District of Columbia 20201 Email: Stephanie. WhittierEliason@acl.hhs.gov Phone: 202-795-7467 Website Address:

http://www.acl.gov

RELATED PROGRAMS:

93.048 Special Programs for the Aging_Title IV_and Title II_Discretionary Projects

EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

Cooperative agreements will be awarded on a competitive basis. Specific details for evaluating applications are published as part of the program announcement. Major emphases are: 1) documented need, 2) expected reach, outcomes and impact, 3) organizational capacity, 4) coordination and partnerships, and 5) strong basis in evidence or theory.

93.748 PPHF COOPERATIVE AGREEMENTS FOR PRESCRIPTION DRUG MONITORING PROGRAM ELECTRONIC HEALTH RECORD (EHR) INTEGRATION AND INTEROPERABILITY EXPANSION PPHF-2012: PDMP EHR Integration and Interoperability (TI-12-011) FEDERAL AGENCY:

Substance Abuse and Mental Health Services Administration, Department of Health and Human Services

AUTHORIZATION:

PDMP EHR Integration and Interoperability cooperative agreements are authorized under Section 509 of the Public Health Service Act, as amended, and are financed by 2012 Prevention and Public Health Funds (PPHF-2012). This announcement addresses Healthy People 2020 Substance Abuse Topic Area HP 2020-SA.

OBJECTIVES:

The purpose of this program is to: 1) improve real-time access to PDMP data by integrating PDMPs into existing technologies like EHRs, in order to improve the ability of State PDMPs to reduce the nature, scope, and extent of prescription drug abuse; and 2) strengthen State PDMPs that are currently operational by providing resources to make the changes necessary to increase interoperability of State PDMPs,

TYPES OF ASSISTANCE:

Cooperative Agreements

USES AND USE RESTRICTIONS:

Applicants that have not yet established interoperability or integration of PDMP into EHR systems must propose implementation of both systems to improve the States ability to reduce prescription drug abuse. Applicants must have an existing PDMP or have an operational PDMP by September 30, 2012, in order to receive an award under this program. An operational PDMP is one that is collecting data and responding to authorized requests for reports. If you do not currently have an operational PDMP, you must submit an assurance in Attachment 2 of your application that you will have one by September 30, 2012. Applicants that do not have an operational PDMP by September 30, 2012, will not be considered for an award. Applicants that have already established interoperability with at least one State or have integrated their PDMP into an EHR system must propose expanding interoperability to multiple State PDMPs and improving real-time access to PDMP data by integrating

PDMPs into existing technologies. No more than 10% of the grant award may

be used for data collection, performance measurement, and performance assessment expenses.

Applicant Eligibility:

Grant funds will enable States to integrate their PDMPs into EHR and other health information technology systems to expand utilization by increasing the production and distribution of unsolicited reports and alerts to prescribers and dispensers of prescription data. Grant funds will also be used by States to allow for modification of their systems to expand interoperability.

Beneficiary Eligibility:

Eligible applicants are the immediate office of the Chief Executive (e.g., Governor) in the 49 States and 1 U.S. territory (i.e., Guam) that have enacted legislation or regulations that permit the following: implementation of a State PDMP; imposition of appropriate penalties for the unauthorized use and disclosure of information maintained in the program; and ability to share PDMP data (de-identified or anonymized) with CDC for research purposes. Eligibility is limited to States/Territory with enacted PDMP legislation because only these States/Territory have the capability to collect the required information and make that information available to prescribers, dispensers, and under controls, other States. PDMPs that are not actively collecting information cannot link their systems to EHRs or share information with other State PDMPs. Due to State laws establishing PDMPs, privacy, confidentiality, security, and other limitations on PDMPs, PDMP EHR Integration and Interoperability grants are limited to State and applicable territorial government entities. Credentials/Documentation:

nature of this project: An operational PDMP is one that is collecting data and responding to authorized request for reports. 2 CFR 200, Subpart E - Cost Principles applies to this program.

Preapplication Coordination:

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application Procedures:

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must download the SF-424 application forms through http://www.samhsa.gov/grants/apply.aspx.

Only the forms package directly attached to a specific Request for Applications (RFA) can be used.

Award Procedure:

Applications are awarded based on the outcomes of the SAMHSA peer review and CSAT National Advisory Council review, and approval by the Administrator, SAMHSA. Grants are awarded directly by SAMHSA to the applicant organization.

Deadlines:

Jun 28, 2012 to Jul 31, 2012: Application are due by July 31, 2012.
Range of Approval/Disapproval Time:

From 60 to 90 days. September 30, 2012.
Appeals:

Not Applicable. Renewals:

Not Applicable.

Formula and Matching Requirements:

This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance:

This program will be funded through one-year Prevention and Public Health
Funds. Method of awarding/releasing assistance: lump sum.
Reports:

All SAMHSA grantees are required to collect and report certain data so that

SAMHSA can meet its obligations under the Government Performance and Results Modernization Act of 2010 (GPRA).

The following GPRA measures have been established for this program:
Number of providers registered with the PDMP;

Number of physicians, pharmacists, and other healthcare providers using the
PDMP;

Number of providers from other states requesting PDMP reports;

Number of unsolicited reports sent to licensure boards and law enforcement (where applicable);

An increase in the number of referrals to substance abuse treatment providers as a result of using the State PDMP;

Percentage of professional partnerships with other healthcare providers that are established (i.e., with substance abuse treatment providers and primary care providers) as a result of using the State PDMP;

Number of unsolicited (proactive) reports sent to practitioners; and Number of EHR or other health information technology systems that have incorporated PDMP data. No cash reports are required. Grantees must periodically review the performance data they report to SAMHSA (as required above) and assess their progress and use this information to improve management of their grant projects. The assessment should be designed to help you determine whether you are achieving the goals, objectives and outcomes you intend to achieve and whether adjustments need to be made to your project. You will be required to report on your progress achieved, barriers encountered, and efforts to overcome these barriers in a performance assessment report to be submitted at least annually. At a minimum, your performance assessment should include the required performance measures identified above. Outcome Questions:

What was the effect of intervention on key outcome goals?

What program/contextual/cultural factors were associated with outcomes?

What individual factors were associated with outcomes?

How durable were the effects?

Process Questions:

How closely did implementation match the plan?

What types of changes were made to the originally proposed plan?

What led to the changes in the original plan?

What effect did the changes have on the planned intervention and performance assessment?. No expenditure reports are required. Grantees will be required to report on progress achieved, barriers encountered, and efforts to overcome these barriers in a performance assessment report to be submitted at least annually.

Audits:

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.

Records:

Records must be retained for at least 3 years; SAMHSA has the right to disallow costs and recover funds on the basis of a later audit or other review; records shall be retained beyond the 3 year period for that reason. Account Identification:

75-1364-0-1-551.

Obligations:

(Cooperative Agreements) FY 16 $0; FY 17 est $0; and FY 18 est $0

Multi-year funding for a total of two 12 month incremental periods within a two year/24 month project period.

Range and Average of Financial Assistance:

No Data Available.

TAFS Codes:

75-1364.

PROGRAM ACCOMPLISHMENTS:

Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:

Not Applicable.

Regional or Local Office:

None. For questions about program issues contact:

Jinhee J. Lee, Pharm.D.

Project Officer

Division of Pharmacologic Therapies

Center for Substance Abuse Treatment

Substance Abuse and Mental Health Services Administration

1 Choke Cherry Road

Room 7 -1028

Rockville, Maryland 20857 (240) 276-0545

jinhee.lee@samhsa.hhs.gov

For questions on grants management and budget issues contact: Eileen Bermudez

Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration

1 Choke Cherry Road

Room 7-1079

Rockville, Maryland 20857

(240) 276-1412

eileen.bermudez@samhsa.hhs.gov. Headquarters Office:

Roger George 5600 Fisher Lane, Rockville, Maryland 20857 Email: roger.george@samhsa.hhs.gov Phone: 2402761418

Website Address:

http://www.samhsa.gov

RELATED PROGRAMS:

Not Applicable.

EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

1. EVALUATION CRITERIA

The Project Narrative describes what you intend to do with your project and includes the Evaluation Criteria in Sections A-E below. Your application will be reviewed and scored according to the quality of your response to the requirements in Sections A-E.

In developing the Project Narrative section of your application, use these instructions, which have been tailored to this program.

The Project Narrative (Sections A-E) together may be no longer than 25 pages.

You must use the five sections/headings listed below in developing your Project Narrative. You must place the required information in the correct section, or it will not be considered. Your application will be scored according to how well you address the requirements for each section of the Project Narrative.

Reviewers will be looking for evidence of cultural competence in each section of the Project Narrative, and will consider how well you address the cultural competence aspects of the evaluation criteria when scoring your application. SAMHSAS guidelines for cultural competence can be found on the SAMHSA Web site at http://www.samhsa.gov/grants/apply.aspx at the bottom of the page under Resources for Grant Writing.

The Supporting Documentation you provide in Sections F-I and Attachments 1 and 2 will be considered by reviewers in assessing your response, along with the material in the Project Narrative.

The number of points after each heading is the maximum number of points a review committee may assign to that section of your Project Narrative. Although scoring weights are not assigned to individual bullets, each bullet is assessed in deriving the overall Section score.

Section A: Statement of Need (10 points)

Indicate if your State has established interoperability or integration of your PDMP into EHR systems.

If it has not, discuss the need to implement either system to improve your States ability to reduce prescription drug use. Explain why interoperability is needed and how use and effectiveness will be improved by linking to EHR

« PreviousContinue »